India and Pakistan: United by Covid-19 Authors Syeda Sidra Fatima 3rd Year Medical Student, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan Samar Faheem 3rd Year Medical Student, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan DOI: https://doi.org/10.47391/JPMA.013935 Abstract Madam, the number of new Covid-19 cases in India peaked at 362,902 on the 27th of April, 2021.1 This is the highest single day total for the world. India sold double the oxygen in 2020-21 than the previous year, now it faces a shortage of medical oxygen as it struggles with rising cases.2 Additionally, it struggles with the vaccine drive. In an article, Kamala Thiagarajan states that the initial block was mistrust of local vaccines, even among frontline healthcare workers. Other conspiracies followed, including fear of price hikes and reports about adverse effects, as approval for its own vaccines was rushed without proper evaluation to ensure safety.3 When adverse effects were observed in AstraZeneca and Johnson & Johnson trials, they were paused to conduct a safety review. However, no such thing occurred during the Covaxin trial.4 Continuous... Downloads Full Text Article Published 2021-11-29 How to Cite Fatima, S. S., & Faheem, S. (2021). India and Pakistan: United by Covid-19. Journal of the Pakistan Medical Association, 71(11), 2695–2695. https://doi.org/10.47391/JPMA.013935 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 71 No. 11 (2021): NOVEMBER Section Letter to the Editor